[{"Assets_0_FY_USD":4800227000.0,"CommonStockSharesOutstanding_0_FY_shares":59820000.0,"EarningsPerShareBasic_1_FY_USD":1.95,"EarningsPerShareBasic_4_FY_USD":6.56,"EarningsPerShareDiluted_1_FY_USD":1.91,"EarningsPerShareDiluted_4_FY_USD":6.41,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":590536000.0,"NetIncomeLoss_1_FY_USD":116689000.0,"NetIncomeLoss_4_FY_USD":396831000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":61870000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":60500000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170228"}]